Table 5.
Association of urine PIIINP with incident CVD, heart failure, and mortality in community-living older adult participants in the CHS
| Urine PIIINP Quartiles | Urine PIIINP Continuous Per SD (3.0 μg/L) | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||
| Urine PIIINP range (μg/L) | ≤1.39 | 1.40–2.58 | 2.59–4.22 | > 4.22 | |
| Incident CVDa | |||||
| No. of events | 75 | 64 | 82 | 68 | |
| No. at risk | 204 | 198 | 212 | 177 | |
| Incidence rate (per 1000 person years) | 39.1 | 33.8 | 44.3 | 48.0 | |
| Demographic adjusted,b HR (95% CI) | 1.00 (reference) | 0.87 (0.62 to 1.23) | 1.19 (0.83 to 1.71) | 1.18 (0.78 to 1.78) | 1.13 (0.97 to 1.31) |
| Fully adjusted,c HR (95% CI) | 1.00 (reference) | 0.77 (0.54 to 1.09) | 0.90 (0.61 to 1.33) | 0.84 (0.54 to 1.32) | 1.00 (0.85 to 1.18) |
| Incident HFd | |||||
| No. of events | 60 | 63 | 68 | 69 | |
| No. at risk | 217 | 215 | 227 | 213 | |
| Incidence rate (per 1000 person years) | 28.3 | 30.8 | 33.8 | 41.7 | |
| Demographic adjusted,b HR (95% CI) | 1.00 (reference) | 1.13 (0.78 to 1.62) | 1.28 (0.86 to 1.89) | 1.44 (0.94 to 2.21) | 1.12 (0.96 to 1.32) |
| Fully adjusted,c HR (95% CI) | 1.00 (reference) | 0.83 (0.57 to 1.21) | 0.79 (0.52 to 1.20) | 0.75 (0.47 to 1.19) | 0.90 (0.75 to 1.08) |
| Death | |||||
| No. of events | 163 | 166 | 165 | 200 | |
| No. at risk | 240 | 239 | 240 | 239 | |
| Incidence rate (per 1000 person years) | 65.9 | 68.3 | 70.4 | 100.2 | |
| Demographic adjusted,b HR (95% CI) | 1.00 (reference) | 1.11 (0.89 to 1.38) | 1.34 (1.05 to 1.72) | 1.87 (1.44 to 2.43) | 1.29 (1.19 to 1.40) |
| Fully adjusted,c HR (95% CI) | 1.00 (reference) | 0.93 (0.74 to 1.18) | 1.04 (0.80 to 1.34) | 1.30 (0.98 to 1.74) | 1.12 (1.03 to 1.23) |
Incident CVD defined as incident MI, stroke, or CVD death. Persons with prevalent CVD at baseline (n=167) were excluded.
Adjusted for age, sex, race, education, clinic site and urine creatinine.
Adjusted for age, sex, race, education, clinical site, urine creatinine, eGFR, urine albumin, smoking status, pack years, body mass index, diabetes, systolic blood pressure, blood pressure medication use, total cholesterol, lipid medication use, and C-reactive protein.
Persons with prevalent HF at baseline (n=86) were excluded.